Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution
2025 · Nature Communications · 43 citations
https://doi.org/10.1038/s41467-025-57108-x
D
David Joy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
52
Papers
1.6K
Citations
19
h-index
23
i10-index
David Joy is an academic researcher from Queensland University of Technology. The author has contributed to research in topics: Pluripotent Stem Cells Research & 3D Printing in Biomedical Research & Cell Image Analysis Techniques. The author has an h-index of 19, co-authored 45 publications.
ORCID: 0000-0001-9941-9538Papers by this author
worksRab12 is a regulator of LRRK2 and its activation by damaged lysosomes
2023 · eLife · 42 citations
https://doi.org/10.7554/elife.87255
Novel high-content and open-source image analysis tools for profiling mitochondrial morphology in neurological cell models
2025 · SLAS DISCOVERY · 3 citations
https://doi.org/10.1016/j.slasd.2025.100208
ETV:SGSH, a brain-penetrant enzyme transport vehicle for SGSH, improves lysosomal and microglial morphology, degeneration and cognitive behavior in MPS IIIA mice
2024 · Molecular Genetics and Metabolism · 0 citations
https://doi.org/10.1016/j.ymgme.2023.107954
Transferrin receptor-mediated transport at the blood-brain barrier is elevated during early development but maintained across adult aging
2024 · bioRxiv (Cold Spring Harbor Laboratory) · 0 citations
https://doi.org/10.1101/2024.11.12.623253
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat